Barrington analyst Alexander Paris reiterated a Buy rating on Healthequity (HQY) today and set a price target of $100. The company’s shares closed yesterday at $67.35.
Paris observed:
“We expect FY/20 revenue of $337.2 million, up 17.4% YOY; adjusted EBITDA of $136.6 million, up 15.4% YOY; and non-GAAP diluted EPS of $1.26, up 5.9% YOY. The FactSet consensus calls for revenue of $337.6 million, adjusted EBITDA of $135.9 million and non-GAAP diluted EPS of $1.27.”
According to TipRanks.com, Paris is a 4-star analyst with an average return of 6.1% and a 50.0% success rate. Paris covers the Services sector, focusing on stocks such as Adtalem Global Education Inc, American Public Education, and Strategic Education Inc.
Currently, the analyst consensus on Healthequity is a Strong Buy with an average price target of $91.33.
See today’s analyst top recommended stocks >>
The company has a one-year high of $101.58 and a one-year low of $50.29. Currently, Healthequity has an average volume of 790.6K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors.
